DEXMEDETOMIDINE VIATRIS dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial Australia - inglese - Department of Health (Therapeutic Goods Administration)

dexmedetomidine viatris dexmedetomidine (as hydrochloride) 200 microgram/2 ml concentrated injection vial

alphapharm pty ltd - dexmedetomidine hydrochloride, quantity: 118 microgram/ml (equivalent: dexmedetomidine, qty 100 microgram/ml) - injection, concentrated - excipient ingredients: nitrogen; water for injections; sodium chloride - icu sedation:,for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of dexmedetomidine viatris by continuous infusion in these patients should not exceed 24 hours.,procedural sedation:,for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

NITROPRUSSIDE-EMC sodium nitroprusside 50 mg/2 mL concentrated injection vial Australia - inglese - Department of Health (Therapeutic Goods Administration)

nitroprusside-emc sodium nitroprusside 50 mg/2 ml concentrated injection vial

emcure pharmaceuticals pty ltd - sodium nitroprusside, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - sodium nitroprusside concentrated injection is indicated for: ,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. ,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. ,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

EPOSIN INFUSION (PARENTERAL) Sudafrica - inglese - South African Health Products Regulatory Authority (SAHPRA)

eposin infusion (parenteral)

teva pharmaceuticals (pty) ltd - infusion (parenteral) - see ingredients - each 1,0 ml concentrate contains etoposide 20,0 mg